(14/05/2023)vs
ΙΑΤΡΙΚΗ ΔΙΑΓΝΩΣΗ ΣΑΛΒΑΡΑ | 20 | 4 | 0 / 00% | 2 / 633.3% | 0 / 20% | 2 / 825% | | 0 | 3 | 0 | 3 | 3 | 0 | 0 | 2 | 2 |
(04/05/2023)vs
ΑΡΚΑΔΕΣ ΠΕΡΙΣΤΕΡΙΟΥ | 30 | 15 | 2 / 2100% | 5 / 1338.5% | 1 / 333.3% | 6 / 1637.5% | | 1 | 6 | 5 | 11 | 3 | 1 | 0 | 3 | 17 |
(26/04/2023)vs
Σ.Ε.ΕΑΒ | 30 | 9 | 7 / 1070% | 1 / 147.1% | 0 / 40% | 1 / 185.6% | | 4 | 0 | 3 | 3 | 3 | 2 | 0 | 3 | -6 |
(23/04/2023)vs
ΑΜΥΝΤΑΣ BC | 31 | 7 | 0 / 00% | 2 / 825% | 1 / 520% | 3 / 1323.1% | | 1 | 3 | 1 | 4 | 6 | 0 | 0 | 7 | 0 |
(02/04/2023)vs
ΑΣΤΡΟΝ ΧΗΜΙΚΑ | 27 | 9 | 0 / 00% | 3 / 560% | 1 / 812.5% | 4 / 1330.8% | | 1 | 2 | 1 | 3 | 3 | 0 | 0 | 4 | 2 |
(30/03/2023)vs
ΑΜΥΝΤΑΣ BC | 37 | 17 | 0 / 00% | 4 / 666.7% | 3 / 742.9% | 7 / 1353.8% | | 4 | 4 | 1 | 5 | 2 | 0 | 0 | 3 | 15 |
(19/03/2023)vs
BST / NIGICO | 26 | 21 | 1 / 1100% | 4 / 666.7% | 4 / 850% | 8 / 1457.1% | | 1 | 3 | 0 | 3 | 2 | 0 | 1 | 2 | 19 |
(15/03/2023)vs
ΜΗΧΜΕ | 10 | 0 | 0 / 20% | 0 / 30% | 0 / 00% | 0 / 30% | | 0 | 0 | 1 | 1 | 1 | 0 | 0 | 1 | -4 |
(12/03/2023)vs
SALFO | 40 | 21 | 2 / 2100% | 8 / 1266.7% | 1 / 714.3% | 9 / 1947.4% | | 3 | 3 | 1 | 4 | 2 | 1 | 0 | 3 | 15 |
(12/02/2023)vs
HEALTHCARE | 40 | 30 | 3 / 3100% | 9 / 1656.3% | 3 / 837.5% | 12 / 2450% | | 3 | 6 | 0 | 6 | 3 | 1 | 0 | 1 | 27 |
(22/01/2023)vs
ΙΑΤΡΙΚΗ ΔΙΑΓΝΩΣΗ ΣΑΛΒΑΡΑ | 24 | 19 | 5 / 683.3% | 4 / 757.1% | 2 / 366.7% | 6 / 1060% | | 1 | 2 | 0 | 2 | 3 | 5 | 0 | 2 | 22 |
(15/01/2023)vs
ΑΜΥΝΤΑΣ BC | 41 | 22 | 0 / 10% | 5 / 1050% | 4 / 1136.4% | 9 / 2142.9% | | 0 | 10 | 0 | 10 | 6 | 3 | 0 | 2 | 26 |
(12/01/2023)vs
ΣΤΕΡΓΙΟΥ | 17 | 6 | 0 / 00% | 3 / 650% | 0 / 30% | 3 / 933.3% | | 1 | 2 | 0 | 2 | 3 | 2 | 0 | 1 | 6 |
(18/12/2022)vs
SALFO | 29 | 14 | 0 / 00% | 7 / 1070% | 0 / 50% | 7 / 1546.7% | | 0 | 9 | 2 | 11 | 8 | 1 | 0 | 2 | 24 |
(04/12/2022)vs
ΑΣΤΡΟΝ ΧΗΜΙΚΑ | 40 | 18 | 3 / 650% | 3 / 933.3% | 3 / 837.5% | 6 / 1735.3% | | 2 | 4 | 0 | 4 | 2 | 1 | 0 | 3 | 8 |
(20/11/2022)vs
BST / NIGICO | 35 | 16 | 2 / 366.7% | 4 / 1526.7% | 2 / 450% | 6 / 1931.6% | | 1 | 2 | 3 | 5 | 2 | 0 | 0 | 2 | 7 |
(13/11/2022)vs
NEW MED | 34 | 20 | 0 / 00% | 7 / 1070% | 2 / 728.6% | 9 / 1752.9% | | 3 | 2 | 2 | 4 | 2 | 0 | 0 | 5 | 13 |
(23/10/2022)vs
ΙΑΤΡΙΚΗ ΔΙΑΓΝΩΣΗ ΣΑΛΒΑΡΑ | 27 | 24 | 1 / 1100% | 7 / 1070% | 3 / 650% | 10 / 1662.5% | | 0 | 3 | 0 | 3 | 6 | 1 | 0 | 1 | 27 |
(16/10/2022)vs
HEALTHCARE | 40 | 22 | 5 / 862.5% | 4 / 850% | 3 / 933.3% | 7 / 1741.2% | | 3 | 5 | 0 | 5 | 3 | 3 | 0 | 3 | 17 |
(09/10/2022)vs
ΥΓΕΙΑ | 34 | 7 | 0 / 00% | 2 / 633.3% | 1 / 812.5% | 3 / 1421.4% | | 1 | 1 | 3 | 4 | 4 | 0 | 0 | 3 | 1 |
(02/10/2022)vs
LP CLINIC | 23 | 14 | 0 / 00% | 4 / 666.7% | 2 / 450% | 6 / 1060% | | 4 | 1 | 0 | 1 | 1 | 1 | 0 | 1 | 12 |
| ΣΥΝΟΛΙΚΑ |
635 |
315 |
31 / 4568.9% |
88 / 18647.3% |
36 / 12030% |
124 / 30640.5% |
|
34 |
71 |
23 |
94 |
68 |
22 |
1 |
54 |
250 |
| ΜΕΣΟΙ ΟΡΟΙ |
30.2 |
15 |
1.5 / 2.168.9% |
4.2 / 8.947.3% |
1.7 / 5.730% |
5.9 / 14.640.5% |
|
1.6 |
3.4 |
1.1 |
4.5 |
3.2 |
1.0 |
0.0 |
2.6 |
11.9 |